Skip to main content
logo
Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
10.19
-0.35 (-3.32%)
Oct 23, 2026, 4:00 PM EDT - Market closed

Climb Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5851911217498278
Market Cap Growth
282.17%57.83%62.54%-23.65%-64.90%-
Enterprise Value
34716-97-33-32108
Last Close Price
10.194.001.802.703.6710.46

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.441.190.570.690.761.66
P/TBV Ratio
2.441.190.570.690.761.66

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.000.000.000.00-
Net Debt / Equity Ratio
-0.99-1.00-1.00-0.99-0.96-0.96
Net Debt / EBITDA Ratio
3.682.36----
Net Debt / FCF Ratio
4.482.9413.625.173.294.47
Quick Ratio
30.8614.4730.6138.5721.3523.79
Current Ratio
31.4515.1631.4138.9222.0424.58
Return on Equity (ROE)
-27.10%-32.15%-46.26%-29.72%-30.58%-50.16%
Return on Assets (ROA)
-18.45%-22.04%-10.30%-10.93%-18.30%-22.54%
Return on Capital Employed (ROCE)
-26.90%-42.20%-12.70%-19.90%-35.00%-21.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.19%-31.34%-61.07%-47.17%-46.40%-17.09%
FCF Yield
-9.07%-28.56%-12.86%-27.67%-38.33%-12.99%
Buyback Yield / Dilution
-2.38%-40.80%-78.47%-2.57%-114.60%-460.40%
SEC Filings: 10-K · 10-Q